Medical Device News Magazine

Eurofins Technologies Launches New SENSIStrip Allergen Product Range: Quickly Detects Allergens That Must Be Labeled On Packaged Food

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

December 14, 2020

Eurofins Technologies, a supplier of test kits and systems for laboratory analyses, announces the launch of the new SENSIStrip Allergen product range, which quickly detects allergens that must be labeled on packaged food products.

Managing food allergies usually means completely eliminating the allergen from one’s diet. To achieve this, consumers rely on clear labeling and traceability throughout the entire food production process, from raw material to the final product.

SENSIStrip Allergen kits are based on the concept of an immunoassay, an easy-to-use and quick method that requires only a few minutes of incubation time. This enables adequate allergen control at different stages of the food manufacturing process, across food matrices, rinse water, and equipment.

With low detection limits and accessibility (the kit does not require the expertise of highly-qualified staff to operate it), the SENSIStrip Allergen kits are the perfect tool to control potential cross-contamination with food allergens, allowing for quick screening of raw materials, the production process, and the final product. This avoids the external analyses and thus considerably reduces the time taken to release a food product batch to market.

The kits are provided with all the necessary and ready-to-use material to perform analysis across 20 individual tests per kit, on food matrices or environmental samples. In addition, an evaluation card is included to enable a semi-quantitative result, based on the intensity of the test line on the strip.

This new product range is a key component of Eurofins Technologies’ food allergen management and cleaning control monitoring solutions which, together with the comprehensive line of SENSISpec ELISA assays for allergen detection, demonstrate Eurofins Technologies’ commitment to providing high-quality test methods for food safety customers.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”